CompliFirst Pharma Consulting, LLC – Trademark Portfolio
Entity Type: 16
CompliFirst Pharma Consulting, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 5 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include YOUR PARTNER IN PHARMA COMPLIANCE, COMPLIFIRST PHARMA CONSULTING, LLC, and DELIVERING SUSTAINABLE COMPLIANCE SOLUTIONS. The owner is based in Raleigh, NC.
5540 Centerview Dr., Ste 200
Raleigh, NC 27606
Showing of trademarks Trademarks
Trademark Classifications
CompliFirst Pharma Consulting, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does CompliFirst Pharma Consulting, LLC have?
CompliFirst Pharma Consulting, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does CompliFirst Pharma Consulting, LLC file in?
CompliFirst Pharma Consulting, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 45 (Legal & Security Services). Class 45 covers legal services; security services for the protection of property and individuals.
What are CompliFirst Pharma Consulting, LLC's most well-known trademarks?
CompliFirst Pharma Consulting, LLC's registered trademark portfolio includes well-known marks such as YOUR PARTNER IN PHARMA COMPLIANCE, COMPLIFIRST PHARMA CONSULTING, LLC, and DELIVERING SUSTAINABLE COMPLIANCE SOLUTIONS. These are among 4 currently registered trademarks in the portfolio.
What is CompliFirst Pharma Consulting, LLC's trademark registration success rate?
CompliFirst Pharma Consulting, LLC has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.